Abstract:Background: Beyond magnetic resonance imaging (MRI), which has been widely used clinically, molecular MRI (mMRI) can further provide qualitative and quantitative information at the cellular and molecular levels. However, the diagnostic accuracy may not be satisfactory via single-contrast mMRI due to some interferences in vivo. T-1/T-2 dual-contrast MRI using the same contrast agent (CA) could significantly improve the detection accuracy. Therefore, in this study, we fabricated poly(ethylene glycol) (PEG)-coated, manganese-doped iron oxide nanocomposites (Mn-IONPs@PEG) as T-1/T-2 dual-contrast CA, and evaluated its feasibility of T-1/T-2 dual-contrast MRI in vitro and in vivo. Methods: Mn-IONPs were prepared by the thermal decomposition of iron-eruciate and manganese-oleate complexes and were coated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-(methoxy[polyethylene glycol]-2000) (DSPE-PEG 2000). The physicochemical properties and cytotoxicity of the Mn-IONPs were fully characterized, followed by MRI in vitro and in vivo. Results: Ultrasmall 3 nm-sized nanoparticles were successfully prepared and were identified using transmission electron microscopy (TEM), high-resolution TEM, and X-ray diffraction. After coating with DSPE-PEG, the Mn-IONPs@PEG displayed excellent hydrophilicity and good biocompatibility. Due to the manganese-doping and PEG coating, the Mn-IONPs@PEG showed good relaxivity in vitro. Especially, the Mn-IONPs@PEG coated with DSPE-PEG following a mass ratio to Mn-IONPs of 1:20 showed harmonious longitudinal relaxivity (r(1) = 7.1 mM(-1) s(-1)) and transversal relaxivity (r(2) = 120.9 mM(-1) s(-1)), making it a better candidate for T-1/T-2 dual-contrast mMRI. After administrated via a caudal vein, the Mn-IONPs@PEG can induce significant enhancement in both T-1-weighted and T-2-weighted MR images and the time at 10 mins after injection was regarded as a suitable time for imaging because both the T-1 and T-2 enhancement were optimum at that time. Conclusion: The obtained Mn-IONPs@PEG exhibited good r(1) and r(2) and was a reasonable candidate for T-1/T-2 dual-contrast mMRI.

Mn(II)-monosubstituted polyoxometalates as candidates for contrast agents in magnetic resonance imaging.

Preparation of Mn2+@PolyDOPA-b-polysarcosine Micelle As MRI Contrast Agent with High Longitudinal Relaxivity

Manganese-Loaded Dual-Mesoporous Silica Spheres for Efficient T1- and T2-Weighted Dual Mode Magnetic Resonance Imaging

Synthesis of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles with High Relaxivity for T1/T2 Dual-Contrast Magnetic Resonance Imaging

Synthesis and in Vitro and in Vivo Evaluation of Manganese(Iii) Porphyrin-Dextran As A Novel Mri Contrast Agent

Manganese Oxide Nanoparticles for MRI-Based Multimodal Imaging and Theranostics

Water-soluble and Biocompatible MnO@PVP Nanoparticles for MR Imaging in Vitro and in Vivo.

Rational Screening of Mn(II) Metal-Ligand Complexes for Using as MRI Contrast Agents Using Machine Learning

A Ph-Responsive T1-T2 Dual-Modal MRI Contrast Agent for Cancer Imaging

Ultrasmall Water‐Soluble and Biocompatible Magnetic Iron Oxide Nanoparticles As Positive and Negative Dual Contrast Agents

Progress in research of magnetic resonance imaging of manganese contrast agent

A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Low-Molecular-Weight Fe(III) Complexes for MRI Contrast Agents

Biocompatible and High-Performance Amino Acids-Capped MnWO4 Nanocasting As a Novel Non-Lanthanide Contrast Agent for X-ray Computed Tomography and T1-weighted Magnetic Resonance Imaging

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

MRI Contrasting Agent Based on Mn-MOF-74 Nanoparticles with Coordinatively Unsaturated Sites

Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive T 1 -Weighted Contrast-Enhanced Brain Imaging

Synthesis, Characterization, and In Vitro Study of Dextrin-Coated Bismuth-Doped Manganese Ferrite Nanoparticles (Bio.3Mno.55Fe2O4) as an MRI Contrast Agent

Rational Design of Magnetic Nanoparticles as T1–T2 Dual-Mode MRI Contrast Agents